Cargando…
Memory markers in the continuum of the Alzheimer’s clinical syndrome
BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526252/ https://www.ncbi.nlm.nih.gov/pubmed/36180965 http://dx.doi.org/10.1186/s13195-022-01082-9 |
_version_ | 1784800838987808768 |
---|---|
author | Parra, Mario A. Calia, Clara Pattan, Vivek Della Sala, Sergio |
author_facet | Parra, Mario A. Calia, Clara Pattan, Vivek Della Sala, Sergio |
author_sort | Parra, Mario A. |
collection | PubMed |
description | BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. METHODS: Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). RESULTS: Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. DISCUSSION: The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01082-9. |
format | Online Article Text |
id | pubmed-9526252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95262522022-10-02 Memory markers in the continuum of the Alzheimer’s clinical syndrome Parra, Mario A. Calia, Clara Pattan, Vivek Della Sala, Sergio Alzheimers Res Ther Research BACKGROUND: The individual and complementary value of the Visual Short-Term Memory Binding Test (VSTMBT) and the Free and Cued Selective Reminding Test (FCSRT) as markers to trace the AD continuum was investigated. It was hypothesised that the VSTMBT would be an early indicator while the FCSRT would inform on imminent progression. METHODS: Healthy older adults (n=70) and patients with mild cognitive impairment (MCI) (n=80) were recruited and followed up between 2012 and 2017. Participants with at least two assessment points entered the study. Using baseline and follow-up assessments four groups were defined: Older adults who were healthy (HOA), with very mild cognitive but not functional impairment (eMCI), and with MCI who did and did not convert to dementia (MCI converters and non-converters). RESULTS: Only the VSTMBT predicted group membership in the very early stages (HOA vs eMCI). As the disease progressed, the FCSRT became a strong predictor excluding the VSTMB from the models. Their complementary value was high during the mid-prodromal stages and decreased in stages closer to dementia. DISCUSSION: The study supports the notion that neuropsychological assessment for AD needs to abandon the notion of one-size-fits-all. A memory toolkit for AD needs to consider tools that are early indicators and tools that suggest imminent progression. The VSTMBT and the FSCRT are such tools. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13195-022-01082-9. BioMed Central 2022-09-30 /pmc/articles/PMC9526252/ /pubmed/36180965 http://dx.doi.org/10.1186/s13195-022-01082-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Parra, Mario A. Calia, Clara Pattan, Vivek Della Sala, Sergio Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title | Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title_full | Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title_fullStr | Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title_full_unstemmed | Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title_short | Memory markers in the continuum of the Alzheimer’s clinical syndrome |
title_sort | memory markers in the continuum of the alzheimer’s clinical syndrome |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526252/ https://www.ncbi.nlm.nih.gov/pubmed/36180965 http://dx.doi.org/10.1186/s13195-022-01082-9 |
work_keys_str_mv | AT parramarioa memorymarkersinthecontinuumofthealzheimersclinicalsyndrome AT caliaclara memorymarkersinthecontinuumofthealzheimersclinicalsyndrome AT pattanvivek memorymarkersinthecontinuumofthealzheimersclinicalsyndrome AT dellasalasergio memorymarkersinthecontinuumofthealzheimersclinicalsyndrome |